Why the study?
Does ranolazine reduce manifestations of ischemia and angina in patients with chronic coronary syndrome?
Does ranolazine reduce manifestations of ischemia and angina in patients with chronic coronary syndrome?
Ranolazine is an effective and safe novel medication for the conservative treatment of stable angina pectoris, reducing ischemia and angina symptoms.
Answers are grounded in this paper and cite their sources.
Should not yet change practice in chronic coronary syndrome; leaves open effects on LV dysfunction and instability.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Pandrc et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: